Literature DB >> 17675514

C-terminal tail phosphorylation of N-formyl peptide receptor: differential recognition of two neutrophil chemoattractant receptors by monoclonal antibodies NFPR1 and NFPR2.

Marcia Riesselman1, Heini M Miettinen, Jeannie M Gripentrog, Connie I Lord, Brendan Mumey, Edward A Dratz, Jamal Stie, Ross M Taylor, Algirdas J Jesaitis.   

Abstract

The N-formyl peptide receptor (FPR), a G protein-coupled receptor that binds proinflammatory chemoattractant peptides, serves as a model receptor for leukocyte chemotaxis. Recombinant histidine-tagged FPR (rHis-FPR) was purified in lysophosphatidyl glycerol (LPG) by Ni(2+)-NTA agarose chromatography to >95% purity with high yield. MALDI-TOF mass analysis (>36% sequence coverage) and immunoblotting confirmed the identity as FPR. The rHis-FPR served as an immunogen for the production of 2 mAbs, NFPR1 and NFPR2, that epitope map to the FPR C-terminal tail sequences, 305-GQDFRERLI-313 and 337-NSTLPSAEVE-346, respectively. Both mAbs specifically immunoblotted rHis-FPR and recombinant FPR (rFPR) expressed in Chinese hamster ovary cells. NFPR1 also recognized recombinant FPRL1, specifically expressed in mouse L fibroblasts. In human neutrophil membranes, both Abs labeled a 45-75 kDa species (peak M(r) approximately 60 kDa) localized primarily in the plasma membrane with a minor component in the lactoferrin-enriched intracellular fractions, consistent with FPR size and localization. NFPR1 also recognized a band of M(r) approximately 40 kDa localized, in equal proportions to the plasma membrane and lactoferrin-enriched fractions, consistent with FPRL1 size and localization. Only NFPR2 was capable of immunoprecipitation of rFPR in detergent extracts. The recognition of rFPR by NFPR2 is lost after exposure of cellular rFPR to f-Met-Leu-Phe (fMLF) and regained after alkaline phosphatase treatment of rFPR-bearing membranes. In neutrophils, NFPR2 immunofluorescence was lost upon fMLF stimulation. Immunoblotting approximately 60 kDa species, after phosphatase treatment of fMLF-stimulated neutrophil membranes, was also enhanced. We conclude that the region 337-346 of FPR becomes phosphorylated after fMLF activation of rFPR-expressing Chinese hamster ovary cells and neutrophils.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17675514     DOI: 10.4049/jimmunol.179.4.2520

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Human neutrophil formyl peptide receptor phosphorylation and the mucosal inflammatory response.

Authors:  Giovanna Leoni; Jeannie Gripentrog; Connie Lord; Marcia Riesselman; Ronen Sumagin; Charles A Parkos; Asma Nusrat; Algirdas J Jesaitis
Journal:  J Leukoc Biol       Date:  2014-11-13       Impact factor: 4.962

2.  Commensal-epithelial signaling mediated via formyl peptide receptors.

Authors:  Christy C Wentworth; Rheinallt M Jones; Young Man Kwon; Asma Nusrat; Andrew S Neish
Journal:  Am J Pathol       Date:  2010-10-29       Impact factor: 4.307

3.  Formyl peptide receptor-mediated ERK1/2 activation occurs through G(i) and is not dependent on beta-arrestin1/2.

Authors:  Jeannie M Gripentrog; Heini M Miettinen
Journal:  Cell Signal       Date:  2007-11-09       Impact factor: 4.315

Review 4.  Annexin A1: shifting the balance towards resolution and repair.

Authors:  Giovanna Leoni; Asma Nusrat
Journal:  Biol Chem       Date:  2016-10-01       Impact factor: 3.915

5.  The leukocyte chemotactic receptor FPR1 is functionally expressed on human lens epithelial cells.

Authors:  Erich H Schneider; Joseph D Weaver; Sonia S Gaur; Brajendra K Tripathi; Algirdas J Jesaitis; Peggy S Zelenka; Ji-Liang Gao; Philip M Murphy
Journal:  J Biol Chem       Date:  2012-09-25       Impact factor: 5.157

6.  Agonist-dependent phosphorylation of the formyl peptide receptor is regulated by the membrane proximal region of the cytoplasmic tail.

Authors:  Elena S Suvorova; Jeannie M Gripentrog; Algirdas J Jesaitis; Heini M Miettinen
Journal:  Biochim Biophys Acta       Date:  2008-10-08

7.  Identification of C-terminal phosphorylation sites of N-formyl peptide receptor-1 (FPR1) in human blood neutrophils.

Authors:  Walid S Maaty; Connie I Lord; Jeannie M Gripentrog; Marcia Riesselman; Gal Keren-Aviram; Ting Liu; Edward A Dratz; Brian Bothner; Algirdas J Jesaitis
Journal:  J Biol Chem       Date:  2013-07-19       Impact factor: 5.157

8.  The Lipidated Peptidomimetic Lau-((S)-Aoc)-(Lys-βNphe)6-NH2 Is a Novel Formyl Peptide Receptor 2 Agonist That Activates Both Human and Mouse Neutrophil NADPH Oxidase.

Authors:  André Holdfeldt; Sarah Line Skovbakke; Malene Winther; Michael Gabl; Christina Nielsen; Iris Perez-Gassol; Camilla Josephine Larsen; Ji Ming Wang; Anna Karlsson; Claes Dahlgren; Huamei Forsman; Henrik Franzyk
Journal:  J Biol Chem       Date:  2016-07-15       Impact factor: 5.157

9.  Biochemical and immunological characterization of a novel monoclonal antibody against mouse leukotriene B4 receptor 1.

Authors:  Fumiyuki Sasaki; Tomoaki Koga; Kazuko Saeki; Toshiaki Okuno; Saiko Kazuno; Tsutomu Fujimura; Yasuyuki Ohkawa; Takehiko Yokomizo
Journal:  PLoS One       Date:  2017-09-18       Impact factor: 3.240

10.  Formyl Met-Leu-Phe-Stimulated FPR1 Phosphorylation in Plate-Adherent Human Neutrophils: Enhanced Proteolysis but Lack of Inhibition by Platelet-Activating Factor.

Authors:  Algirdas J Jesaitis; Jeannie Gripentrog; Jovanka M Voyich
Journal:  J Immunol Res       Date:  2018-01-24       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.